4D制药ADR吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
222 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-06 02:46
229 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-30 02:46
190 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-25 05:35
195 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-24 21:38
195 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-02 06:44
265 0 公告 Notice of Effectiveness 4D制药ADR资讯 04-29 18:47
210 0 公告 [Cover]Correspondence 4D制药ADR资讯 04-26 00:00
210 0 公告 [Cover]SEC-generated letter 4D制药ADR资讯 04-26 00:00
337 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 04-22 04:39
403 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-05 00:44
359 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 04-02 05:26
361 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-01 05:55
317 0 公告 Notice of Effectiveness 4D制药ADR资讯 03-31 19:09
344 0 公告 [Amend] Registration statement by foreign private 4D制药ADR资讯 03-29 05:50
296 0 公告 [Cover]Correspondence 4D制药ADR资讯 03-28 00:00
567 1 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 23:13
402 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 03-09 06:32
375 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 03-03 07:58
398 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 03-01 06:44
389 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-26 07:33
412 0 公告 [Amend] Report of foreign issuer [Rules 13a-16 and 4D制药ADR资讯 02-19 06:34
445 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
392 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
379 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-18 21:29
430 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 02-03 23:51
489 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-03 07:02
487 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-03 05:05
418 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
420 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
377 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 01-06 05:15
458 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 12-15 00:46
449 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-15 18:50
400 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-15 05:15
517 0 公告 [Amend] Registration statement for certain foreign 4D制药ADR资讯 10-07 18:26
492 0 公告 Post-Effective amendments for registration stateme 4D制药ADR资讯 10-01 18:51
469 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 10-01 18:42
468 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-01 18:31
488 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-01 00:00
514 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-30 18:44
478 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-24 05:07
604 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 09-14 19:32
455 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 08-12 03:47
543 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 08-02 23:41
566 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-28 05:48
452 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 07-28 04:50
775 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-08 00:29
499 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-05 04:17
474 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:36
461 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:17
529 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 05-25 21:10
497 0 公告 Notice of Effectiveness 4D制药ADR资讯 05-25 18:38
517 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 05-01 06:14
517 0 公告 [Amend] Annual and transition report of foreign pr 4D制药ADR资讯 05-01 05:39
544 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 04-24 04:27
506 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
536 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
519 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 04-12 18:19
550 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-02 18:20
550 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-01 19:25
539 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 03:21
496 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-19 02:13
574 0 公告 Certification by an exchange approving securities 4D制药ADR资讯 03-18 22:13
460 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-18 05:03
477 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-17 21:54
480 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 03-09 05:35
602 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
524 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
529 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-26 21:41
516 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:34
500 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:28
517 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:26
541 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:15
631 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-25 06:59
360 0 公告 SEC Staff Letter: REDACTED EXHIBIT 4D制药ADR资讯 02-25 00:00
467 0 公告 Registration of securities [Section 12(b)] 4D制药ADR资讯 02-24 07:45
469 0 公告 [Cover]Correspondence 4D制药ADR资讯 02-24 00:00
410 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-19 00:00
392 0 公告 Registration of American Depository Receipt shares 4D制药ADR资讯 02-18 00:00
391 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-16 00:00
384 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-08 00:00
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
郑重声明：用户在社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接